0001736293-22-000001.txt : 20220228 0001736293-22-000001.hdr.sgml : 20220228 20220228152616 ACCESSION NUMBER: 0001736293-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220228 DATE AS OF CHANGE: 20220228 EFFECTIVENESS DATE: 20220228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SeLux Diagnostics, Inc. CENTRAL INDEX KEY: 0001736293 IRS NUMBER: 472384587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-435236 FILM NUMBER: 22688740 BUSINESS ADDRESS: STREET 1: 56 ROLAND STREET STREET 2: SUITE 206 CITY: CHARLESTOWN STATE: MA ZIP: 02129 BUSINESS PHONE: 617-945-9383 MAIL ADDRESS: STREET 1: 56 ROLAND STREET STREET 2: SUITE 206 CITY: CHARLESTOWN STATE: MA ZIP: 02129 D 1 primary_doc.xml X0708 D LIVE 0001736293 SeLux Diagnostics, Inc. 56 ROLAND STREET SUITE 206 CHARLESTOWN MA MASSACHUSETTS 02129 617-945-9383 DELAWARE None None Corporation true Steven E. Lufkin c/o SeLux Diagnostics, Inc. 56 Roland Street, Suite 206 Charlestown MA MASSACHUSETTS 02129 Executive Officer Director Aleksandar Vacic c/o SeLux Diagnostics, Inc. 56 Roland Street, Suite 206 Charlestown MA MASSACHUSETTS 02129 Executive Officer Eric Stern c/o SeLux Diagnostics, Inc. 56 Roland Street, Suite 206 Charlestown MA MASSACHUSETTS 02129 Executive Officer Director James Parker Cassidy c/o SeLux Diagnostics, Inc. 56 Roland Street, Suite 206 Charlestown MA MASSACHUSETTS 02129 Director Scott Yaphe c/o SeLux Diagnostics, Inc. 56 Roland Street, Suite 206 Charlestown MA MASSACHUSETTS 02129 Director Erich Scheller c/o SeLux Diagnostics, Inc. 56 Roland Street, Suite 206 Charlestown MA MASSACHUSETTS 02129 Director Mr. Scheller was elected as a Director upon the Date of First Sale. Jack Percoskie c/o SeLux Diagnostics, Inc. 56 Roland Street, Suite 206 Charlestown MA MASSACHUSETTS 02129 Executive Officer Biotechnology Decline to Disclose 06b false 2022-02-11 false true false 0 57613735 48175947 9437788 Amounts include conversion of outstanding convertible securities. true 0 25 0 0 0 false SeLux Diagnostics, Inc. Steven E. Lufkin Steven E. Lufkin Chief Executive Officer 2022-02-28